dc.date.accessioned2016-11-29T20:54:03Z
dc.date.available2016-11-29T20:54:03Z
dc.date.created2016-11-29T20:54:03Z
dc.date.issued2014
dc.identifier0263-6352
dc.identifierhttp://hdl.handle.net/10533/134318
dc.identifier1100874
dc.identifierWOS:000333301000013
dc.identifier1473-5598
dc.languageeng
dc.publisherGOWER MEDICAL PUBLISHING
dc.relationhttps://doi.org/10.1097/HJH.0000000000000094
dc.relation10.1097/HJH.0000000000000094
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1100874
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleAngiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/ang ii axis
dc.typeArticulo


Este ítem pertenece a la siguiente institución